No Data
No Data
Leerink Partners Maintains Applied Therapeutics(APLT.US) With Buy Rating, Announces Target Price $3
Analysts' Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Applied Therapeutics (APLT)
RBC Capital Maintains Applied Therapeutics(APLT.US) With Hold Rating, Maintains Target Price $1.5
Applied Therapeutics Reports 2024 Financial Results and Leadership Changes
Applied Therapeutics | 10-K: FY2024 Annual Report
Applied Therapeutics | 8-K: Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results